ArticleBMC cancer2024

Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.

Jingjing Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.